Government Signs Deal For COVID-19 Treatments From Eli Lilly
The federal government plans to distribute 300,000 doses of the drug at no cost, but that doesn't mean treatment will be free. Intravenous infusion charges can run more than $1,000.
by Richard Harris
Oct 28, 2020
3 minutes
Eli Lilly has struck a deal with the federal government to provide 300,000 doses of a drug that's designed to keep people infected with COVID-19 out of the hospital. The cost per dose: $1,250.
The federal government plans to distribute the 300,000 doses at no cost, but that doesn't mean treatment will be free.
The Lilly drug, a type of monoclonal antibody, is given by intravenous infusion. Those infusions, typically given in hospitals or standalone clinics, can cost well over $1,000. People with
You’re reading a preview, subscribe to read more.
Start your free 30 days